A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule)
Clinical trial NCT03168412 · COMPLETED
Trial details
- NCT number
- NCT03168412
- Sponsor
- Xiamen Innovax Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-25
- Primary completion
- 2018-07-15
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.